Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renren Bai

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Journal of Medicinal Chemistry|November 12, 2025
Discovery of Novel Dihydroxyphenol Tyrosinase Inhibitors for Treatment of Pigmentation: From Enzyme Screening to Three-Dimensional Human Skin Melanin EvaluationJiahui Wang, Yinyan Sun, Xiaoying Jiang, et al.
Journal of Medicinal Chemistry|June 12, 2024
Synthetically Feasible De Novo Molecular Design of Leads Based on a Reinforcement Learning Model: AI-Assisted Discovery of an Anti-IBD Lead Targeting CXCR4Xiaoying Jiang, Liuxin Lu, Junjie Li, et al.
European Journal of Medicinal Chemistry|April 15, 2019
Development of CXCR4 modulators based on the lead compound RB-108Renren Bai, Xiaokang Jie, Jian Sun, et al.
Journal of Advanced Research|December 30, 2025
Strategy and efficiency-redefined discovery of novel nanomolar tyrosinase inhibitors: AI de novo molecular generation + expert-guided structural optimizationYinyan Sun, Jiahui Wang, Wenchao Chen, et al.
Journal of Medicinal Chemistry|May 24, 2021
Discovery of Novel Tacrine-Pyrimidone Hybrids as Potent Dual AChE/GSK-3 Inhibitors for the Treatment of Alzheimer's DiseaseHong Yao, Giuseppe Uras, Pengfei Zhang, et al.
Journal of Medicinal Chemistry|April 23, 2024
Artificial Intelligence-Assisted Optimization of Antipigmentation Tyrosinase Inhibitors: <i>De Novo</i> Molecular Generation Based on a Low Activity Lead CompoundHong Cai, Wenchao Chen, Jing Jiang, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Journal of Medicinal Chemistry|November 12, 2025
Discovery of Novel Dihydroxyphenol Tyrosinase Inhibitors for Treatment of Pigmentation: From Enzyme Screening to Three-Dimensional Human Skin Melanin EvaluationJiahui Wang, Yinyan Sun, Xiaoying Jiang, et al.
Journal of Medicinal Chemistry|June 12, 2024
Synthetically Feasible De Novo Molecular Design of Leads Based on a Reinforcement Learning Model: AI-Assisted Discovery of an Anti-IBD Lead Targeting CXCR4Xiaoying Jiang, Liuxin Lu, Junjie Li, et al.
European Journal of Medicinal Chemistry|April 15, 2019
Development of CXCR4 modulators based on the lead compound RB-108Renren Bai, Xiaokang Jie, Jian Sun, et al.
Journal of Advanced Research|December 30, 2025
Strategy and efficiency-redefined discovery of novel nanomolar tyrosinase inhibitors: AI de novo molecular generation + expert-guided structural optimizationYinyan Sun, Jiahui Wang, Wenchao Chen, et al.
Journal of Medicinal Chemistry|May 24, 2021
Discovery of Novel Tacrine-Pyrimidone Hybrids as Potent Dual AChE/GSK-3 Inhibitors for the Treatment of Alzheimer's DiseaseHong Yao, Giuseppe Uras, Pengfei Zhang, et al.
Journal of Medicinal Chemistry|April 23, 2024
Artificial Intelligence-Assisted Optimization of Antipigmentation Tyrosinase Inhibitors: <i>De Novo</i> Molecular Generation Based on a Low Activity Lead CompoundHong Cai, Wenchao Chen, Jing Jiang, et al.
Pageof 8